Humanized Anti-Human MS4A1 Therapeutic Antibody

Ask supplier a question | View on supplier's website

This antibody is a humanized single chain version of Rituximab through CDR grafting method, which is able to to inhibit growth of CD20-expressing cancers.

Supplier	Creative Biolabs
Product #	TAB-1689CL
Pricing	Inquiry
Type	Humanized antibody
Host	Human
Target	CD20

Feedback